Incyte | INCY - Ingresos Por Ventas

Precio De Mercado
96.84
Cambio Diario
0.62 0.64%
Mensual
7.06%
Anual
66.97%
Q2 Expectativa
95.67




Ventas Cambio Fecha
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Agenus USD 34.2M 3.97M 2025-12
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amgen USD 9.9B 340M 2025-12
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Exelixis USD 598.66M 860K 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Incyte USD 1.51B 140M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
MacroGenics USD 41.23M 31.61M 2025-12
Merck USD 16.4B 880M 2025-12
Moderna USD 678M 342M 2025-12
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 13.86B 50M 2025-12
Novartis USD 13.86B 498M 2025-12
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 164.7M 46.3M 2025-12
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12